Sugammadex: a selective relaxant-binding agent providing rapid reversal
Authors:
- Urs A BergnerUBUrs A Bergner
- Friedrich K PühringerFPFriedrich K Pühringer
- 1 August 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Anaesthesiology
- Vol. 23 (4) , 461-465
Abstract
Sugammadex is a new reversal agent with a unique mechanism of action in anaesthesia. Because of its rapid onset of action and its efficacy in determining neuromuscular blockade at any time, it opens up new perspectives in anaesthesia. During the last few years, a lot of phase II and III studies have been published, investigating various groups of patients and clinical situations. Sugammadex has been shown to be a well tolerated drug, which appears to meet every challenge it is presented with in daily clinical practice. Sugammadex binds amino-steroidal muscle relaxants by encapsulation. It enables rapid reversal of neuromuscular blockade at any time point and at any depth of block. Its effects are predictable and very reliable, in contrast to cholinesterase inhibitors. This opens up new perspectives in anaesthesia. Even an emergency reversal of high-dose rocuronium-induced neuromuscular blockade is possible with sugammadex and times to full recovery (TOF 0.9) are faster than after spontaneous recovery from suxamethonium.Keywords
This publication has 21 references indexed in Scilit:
- Reversal of Neuromuscular Blockade by Sugammadex after Continuous Infusion of Rocuronium in Patients Randomized to Sevoflurane or Propofol Maintenance AnesthesiaAnesthesiology, 2009
- Reversal of Profound Rocuronium-induced Blockade with SugammadexAnesthesiology, 2008
- Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmineBritish Journal of Anaesthesia, 2008
- Early Reversal of Profound Rocuronium-induced Neuromuscular Blockade by Sugammadex in a Randomized Multicenter Study: Efficacy, Safety, and PharmacokineticsAnesthesiology, 2007
- Sugammadex: Another Milestone in Clinical Neuromuscular PharmacologyAnesthesia & Analgesia, 2007
- Reversal of Rocuronium-Induced Neuromuscular Block with the Novel Drug Sugammadex Is Equally Effective Under Maintenance Anesthesia with Propofol or SevofluraneAnesthesia & Analgesia, 2007
- A Randomized, Dose-Finding, Phase II Study of the Selective Relaxant Binding Drug, Sugammadex, Capable of Safely Reversing Profound Rocuronium-Induced Neuromuscular BlockAnesthesia & Analgesia, 2007
- Effective Reversal of Moderate Rocuronium- or Vecuronium-induced Neuromuscular Block with Sugammadex, a Selective Relaxant Binding AgentAnesthesiology, 2007
- First Human Exposure of Org 25969, a Novel Agent to Reverse the Action of Rocuronium BromideAnesthesiology, 2005
- Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and StabilizationJournal of Pharmaceutical Sciences, 1996